Ling Gao

发表

Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials.

Q. Wang, Qiu Li, Lu Liu, 2018, Diabetes research and clinical practice.

Unsatisfactory Glucose Management and Adverse Pregnancy Outcomes of Gestational Diabetes Mellitus in the Real World of Clinical Practice: A Retrospective Study

Changting Zuo, Lu Liu, Ling Gao, 2018, Chinese medical journal.

Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis

Xiaoyan Wu, Lihua Ni, Ling Gao, 2022, Frontiers in Endocrinology.

Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China.

P. Wang, G. Ning, Qiang Li, 2016, Journal of clinical lipidology.

Identification of the Chinese Population That Can Benefit Most From Postprandial Lipid Testing: Validation of the Use of Oral Fat Tolerance Testing in Clinical Practice

X. Xing, L. Ren, Yong Tang, 2022, Frontiers in Endocrinology.

A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center setting

Zhongshang Yuan, Zuojie Luo, Xulei Tang, 2018, BMC Endocrine Disorders.

Glycaemic responses in Asian and non-Asian people with type 2 diabetes initiating insulin glargine 100 units/mL: A patient-level pooled analysis of 16 randomised controlled trials.

J. Chan, S. Tsai, S. Chan, 2018, Diabetes research and clinical practice.

Efficacy and Safety of Insulin Glargine Compared to Other Interventions in Younger and Older Adults: A Pooled Analysis of Nine Open-Label, Randomized Controlled Trials in Patients with Type 2 Diabetes

A. Digenio, Meenakshi Patel, N. Pandya, 2013, Drugs & Aging.

The Predictive Value of Serum Calcium on Heart Rate Variability and Cardiac Function in Type 2 Diabetes Patients

Yingchun Ye, L. Wan, Deng Luo, 2022, Frontiers in Endocrinology.

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL

M. Hanefeld, W. Landgraf, Ling Gao, 2017, Cardiovascular Diabetology.

Beneficial effects of designed dietary fatty acid compositions on lipids in triacylglycerol-rich lipoproteins among Chinese patients with type 2 diabetes mellitus.

V. Vaccarino, N. Le, E. Veledar, 2009, Metabolism: clinical and experimental.

Influence of Baseline Glycemia on Outcomes With Insulin Glargine Use in Patients Uncontrolled on Oral Agents

L. Blonde, M. Banerji, M. Baron, 2014, Postgraduate medicine.

Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis

A. Chang, J. Halter, C. Blaum, 2012, Journal of the American Geriatrics Society.

Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.

W. Polonsky, Wenhui Wei, A. Vlajnic, 2017, Journal of diabetes and its complications.